SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

UBS Maintains Buy Rating on Kelun-Biotech

UBS maintained its Buy rating on Kelun-Biotech.

SquawkNews Desk

Related stories

National Hotels Q3 Hotel Services Revenue 1.1 Million Dinars National Hotels reported Q3 hotel services revenue of 1.1 million dinars. M impact | EQUITY | Oct 29, 2026, 11:55 AM UTC HSBC Announces Dividend of R$ 0.6379187050 per Unit HSBC Holdings announced a dividend of R$ 0.6379187050 per unit. M impact | EQUITY | Oct 29, 2026, 11:55 AM UTC XPO Reports Q3 Adjusted Earnings of $1.70 XPO reported third-quarter adjusted earnings of $1.70. M impact | EQUITY | Oct 29, 2026, 11:55 AM UTC Howmet Aerospace Announces $5 Billion Buyback, Raises 2026 Guidance Howmet Aerospace announced a new $5 billion share buyback authorization after reporting third-quarter earnings above estimates and raising its full-year 2026 guidance. M impact | EQUITY | Oct 29, 2026, 11:55 AM UTC China Longyuan Power Q3 Net Profit Falls 57.84% Y/Y M impact | EQUITY | Oct 29, 2026, 11:54 AM UTC Saia 3Q LTL Tonnage Per Workday Rose 8.9% M impact | EQUITY | Oct 29, 2026, 11:54 AM UTC